• CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute , 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More CLSI Standards PDF

CSA Z16686:20

CSA Z16686:20

$68.00 $136.00

CSA Z275.2:20

CSA Z275.2:20

$74.00 $149.00

CSA C22.2 NO. 115:20

CSA C22.2 NO. 115:20

$52.00 $105.00

CSA C22.2 NO. 60335-2-36:20

CSA C22.2 NO. 60335-2-36:20

$130.00 $260.00